Our study evaluated the outcomes of cervical cancer patients with FIGO stage IB1-IIA1 who underwent radical surgery at the time of diagnosis at Vietnam National Cancer Hospital. Method: We conducted a retrospective study on 158 cervical cancer patients with FIGO stage IB1-IIA1, who received radical hysterectomy from January 2016 to January 2019.